Literature DB >> 11157916

Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates.

F J Schmitz, A Krey, R Sadurski, J Verhoef, D Milatovic, A C Fluit.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11157916     DOI： 10.1093/jac/47.2.239

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  23 in total

1.  Antibiotic resistance in Staphylococcus isolates obtained from fecal samples of healthy children.

Authors:  Elena Domínguez; Myriam Zarazaga; Carmen Torres
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

2.  Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates.

Authors:  D Milatovic; F-J Schmitz; J Verhoef; A C Fluit
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model.

Authors:  Stephanie DeLeon; Allie Clinton; Haley Fowler; Jake Everett; Alexander R Horswill; Kendra P Rumbaugh
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

4.  Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.

Authors:  Ad C Fluit; Alice Florijn; Jan Verhoef; Dana Milatovic
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Diagnostic PCR analysis of the occurrence of methicillin and tetracycline resistance genes among Staphylococcus aureus isolates from phase 3 clinical trials of tigecycline for complicated skin and skin structure infections.

Authors:  C Hal Jones; Margareta Tuckman; Anita Y M Howe; Mark Orlowski; Stanley Mullen; Karen Chan; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

6.  In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals.

Authors:  Olivier Denis; Ariane Deplano; Claire Nonhoff; Marie Hallin; Raf De Ryck; Raymond Vanhoof; Ricardo De Mendonça; Marc J Struelens
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

7.  Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin.

Authors:  Tatiana Bogdanovich; Lois M Ednie; Stuart Shapiro; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

8.  Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States.

Authors:  Linda K McDougal; Gregory E Fosheim; Ainsley Nicholson; Sandra N Bulens; Brandi M Limbago; Julia E S Shearer; Anne O Summers; Jean B Patel
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

9.  Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  Jörg J Ruhe; Anupama Menon
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

10.  Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus.

Authors:  Birgit Strommenger; Christiane Kettlitz; Guido Werner; Wolfgang Witte
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.